[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@BiopharmIQ BiopharmIQ by Amp

Several biotech companies have recently made significant announcements, including $INBX, which saw a XX% increase in stock value after releasing positive topline results for its chondrosarcoma trial. $RNA entered into an acquisition agreement for $XX billion, and $NVS is set to acquire $RNA's neuro pipeline. Additionally, $GMAB is acquiring $MRUS for $X billion, expanding its portfolio with a phase X bispecific petosemtamab.

Engagements: XXXXXX #

X Week XXXXXXX +56%
X Month XXXXXXX -XX%
X Months XXXXXXXXX +20%
X Year XXXXXXXXX -XX%

Mentions: XX #

X Week XX no change
X Month XXX -XX%
X Months XXX -XX%
X Year XXXXX -XX%

Followers: XXXXXX #

X Week XXXXXX +0.59%
X Month XXXXXX +1.60%
X Months XXXXXX +14%
X Year XXXXXX +23%

CreatorRank: XXXXXXX #

Social Influence

Social category influence stocks XXXXX% cryptocurrencies #3248 finance XXXX% countries XXXX% exchanges XXXX% technology brands XXXX% currencies XXXX%

Social topic influence $gpcr #1, $aclx #1, $ewtx #1, $nktr #4, $xcur #1, $incy #2, $iron #1, $rzlt #2, $argx #3, $prax #11

Top accounts mentioned or mentioned by @yaireinhorn @bowtiedbiotech @andreagtc @learnbiotech @bowtiedbiotechs @quantumup1 @drsamuelbhume @persimmonti @ohadhammer @amaymd @biotech2k1 @geneinvesting @pharmdca @bioinvestor24 @biostocks @rheumatdocx @hatedmoats @seedy19tron @avidresearch @bananaoncology

Top Social Posts

Top posts by engagements in the last XX hours

"📣 Biotech Stock News 12/04 @ Open $AXGN XX% FDA Approves of BLA for AVANCE $BIOA XX% Positive Interim Ph1 Data for BGE-102 $ABSI X% First Participants Dosed in Trial $PTHS X% Major Pharmacy Benefit Manager Agreement $PPBT X% New Preclinical Data at ESMO-IO 2025 $INTS X% Two Presentations at Breast Cancer Symposium $APLS X% Positive Phase X Results for C3G $BFRI X% Last Patient Completes Phase X Study $CATX X% Acceptance of VMT--NET Data for Presentation $ORIC X% Late-Breaking Oral Presentations at ESMO $ENLV X% Fireside Chat on RAIN Token Strategy $PSTV X% Highlights Three REYOBIQ Clinical"
X Link 2025-12-04T15:28Z 28.1K followers, 4970 engagements

"📣 Biotech Stock News 07/24 @ Midday $TELO XX% Restores Mitochondrial Health in Cells $IDYA X% Oral Presentation at ESMO 2025 $ATRA X% FDA Acceptance and Priority Review for Tabelecleucel $ANNX X% Completion of Enrollment in ARCHER II Trial $UNCY X% Publication of Oxylanthanum Carbonate Trial Data $ABVX X% Pricing of $650M Public Offering $RHHBY X% Showcases science-driven leadership and innovation $VSTM X% Fast Track Designation for VS-7375 $MNOV X% Enrollment Update for ALS Trials $CADL X% EMA Orphan Designation for CAN-2409 $LLY X% Expiration of Tender Offer $ANIX X% New U.S. Patent for"
X Link 2025-07-24T15:56Z 28.1K followers, 5973 engagements

"Perceptive Advisors 🔔 🐳 Q3 25* Holdings Released Holdings: XX Holdings in Top 20: XXXXX% Qtr over Qtr Change**: XXXXX% Top Holdings: $RYTM (7.1%) $ASND (6.2%) $ACLX (5.9%) $CELC (4.2%) $NUVL (3.9%) $MRUS (3.7%) $AMLX (3.5%) $ROIV (3.2%) $MGTX (3%) $INSM (2.9%) $TVTX (2.6%) $AORT (2.5%) $PRAX (2.4%) $IMTX (2.3%) $CNTA (2.2%) $SLDB (2.1%) $PTGX (2%) $NBIX (1.8%) $EWTX (1.8%) $VRNA (1.6%) *Holdings as of 9/30/25 in SEC form 13F **Change in value of public company shares held See image for more details 👇"
X Link 2025-11-14T23:56Z 28.1K followers, 4957 engagements

"🧬 Biotech Stock News 11/20 @ Open $EVAX XX% Positive data for CMV vaccine program $GANX X% Preclinical GT-02287 Data Presented $CGEM X% Rolling Submission for New Drug Application $REGN X% FDA Approves Injection for Macular Edema $HUMA X% Presentations Highlight Positive ATEV Clinical Results $PRTA X% Poster Presentation on TDP-43 Program $NUVL X% FDA Accepts New Drug Application $AGEN X% End-of-Year Stakeholder Webcast on GI Oncology $PTCT X% To Host R&D Day $OCGN X% CEO to Present at Emerging Growth Conference $MAIA X% Telomere Targeting Efficacy Presentation $ONC X% Leadership in B-cell"
X Link 2025-11-20T16:05Z 28.1K followers, 5424 engagements

"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q4 2025 (2/2). $ZVSA Phase 2a $CGON Phase X $VTYX Phase X $DBVT Phase X $PHVS Phase X $VTGN Phase X $PRAX Phase X $INBX Phase 2/3 $MLTX Phase X $BLTE Phase X $ADVM Phase X $ALT Phase 2b $RYTM Phase X $INSM Phase X $KMDA Phase X $MREO Phase X $RHHBY Phase X $TRAW Phase X $RARE Phase X $GPCR Phase 2b $ZBIO Phase X $ADCT Phase X $SLS Phase X $PCVX Phase X $IMMP Phase 2/3 $ALDX Phase X $ALNY Phase X $LLY Phase X $FBIO Phase X $IONS Phase X $REGN Phase 2/3 $CALT Phase X $GNFT Phase X $NAMS Phase X $PBYI Phase X $KZIA Phase X $NVS Phase X $NAMS"
X Link 2025-11-30T21:25Z 28.1K followers, 1492 engagements

"Each quarter we identify major catalyst events 🥳 Likely to move the stock +/- by XX% $IRON DISC-0974 $NKTR Rezpegaldesleukin (NKTR-358) $MGNX Lorigerlimab + docetaxel Access our FREE Big Mover Report"
X Link 2025-11-30T21:25Z 28.1K followers, 3296 engagements

"Let's see how many of the XX biopharma-focused hedge funds hold these tickers. $IRON 10/34 🔥 $NKTR 6/34 $MGNX 3/34 Access our FREE hedge fund screener & search your fav tickers"
X Link 2025-11-30T21:25Z 28.1K followers, 2420 engagements

"📌 Biotech Stock News 12/2 @ Open $NRXP X% FDA Receives ANDA for KETAFREE $JSPR X% ETESIAN Study Positive Data $TLSA X% Plans to Spinout IL-6 Asset $SGMO X% FDA Fast Track for ST-503 $PDSB X% Scheduling of Type C Meeting with FDA $RHHBY X% FDA Clearance for Point-of-Care Test $BFRI X% Filing of sNDA for sBCC Treatment $ARWR X% Plozasiran Breakthrough Tx Designation $ENGN X% Detalimogene Selected for FDA Pilot $PCRX X% 12-Month Study Shows Pain Improvement $LGVN X% Granted Patent for Stem Cell Method $HRMY X% New Data from Phase X ARGUS Trial $NTRA X% Presenting XX Datasets at Symposium $JAGX"
X Link 2025-12-02T16:48Z 28.1K followers, 4060 engagements

"📣 Biotech Stock News 12/08 @ Open $WVE XXX% Positive Interim Data from INLIGHT Trial $GPCR XX% Positive Topline Data from ACCESS Program $IMMP XX% Strategic Collaboration for Oncology Drug $KYMR XX% Positive Results from Phase 1b Trial $OCUL XX% Accelerate NDA Submission Timeline for AXPAXLI $DYN XX% Positive Topline Results from DELIVER Trial $ARWR XX% Phase 1/2a Study of ARO-MAPT $CHRS XX% JUPITER-02 Follow-up Results Show Survival Increase $PRME XX% Publication of PM359 Clinical Data $PRAX X% Best-in-Class Potential in Epilepsies $GLSI X% Completion of Enrollment in FLAMINGO-01 $ABEO 5%"
X Link 2025-12-08T17:06Z 28.1K followers, 14.2K engagements

"$XCUR up XX% 📈 Burixafor Ph2: MM mobilization XX% achieved primary endpoint goal Safe with daratumumab-exposed patients Don't miss out on future Big Movers Access our FREE Big Mover Report 👇"
X Link 2025-12-10T16:17Z 28.1K followers, XXX engagements

"📣 Biotech Stock News 12/11 @ Open $RYTM XX% Setmelanotide shows positive efficacy $RNAZ XX% Ph2a trial with TTX-MC138 $ACIU XX% Positive Ph2 Data on ACI-7104.056 $OKYO XX% New data for neuropathic corneal pain $ATOS XX% FDA Designation for (Z)-Endoxifen $BYSI XX% Survival Benefit of Plinabulin + Docetaxel $BHVN XX% Clinical data for BHV-1510 & Cemiplimab $GERN X% Strategic Restructuring Plan Announced $ADXN X% Amends at the Market Offering $MAIA X% First Patient Dosed in THIO-104 Trial; Insider Buying and Trial Data $AARD X% First Patient Dosed in HERO Trial $CVKD X% Acquires VLX-1005 for"
X Link 2025-12-11T16:09Z 28.1K followers, 5173 engagements

"🧬 Biotech Stock News 08/29 Brought to you by Barb X on the rise 📈 $ONC X under pressure 📉 $IRTC $ESPR Catch the full breakdown in the latest video 🎥"
X Link 2025-08-29T16:59Z 28.1K followers, 3025 engagements

"100% approval month 💥 Every drug/PDUFA in Oct got approved $JAZZ Zepzelca + Tecentriq $ARQT ZORYVE (roflumilast) Cream XXXX% $AMGN Tezspire $GKOS Epioxa (Epi-on) $GSK Blenrep combinations (BVd & BPd) $SNDX Revuforj (revumenib) $MRK WINREVAIR (sotatercept-csrk) $RHHBY Gazyva/Gazyvaro $REGN Libtayo (cemiplimab) Updated calendar below"
X Link 2025-11-03T20:39Z 28.1K followers, 24.5K engagements

"November Biotech PDUFA Pulse: 📡 Whats on the FDA Radar $ARWR - Plozasiran (ARO-APOC3) $KURA - Ziftomenib $ASND - TransCon CNP See this months PDUFA calendar below"
X Link 2025-11-03T22:23Z 28.1K followers, 41K engagements

"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q4 2025 (1/2). $LGVN Phase 2a $INMB Phase X $AVXL Phase 2/3 $STOK Phase X $ACLX Phase X $IRON Phase X $GLPG Phase X $NRIX Phase X $XCUR Phase X $PVLA Phase X $COGT Phase X $NKTR Phase 2b $RZLT Phase X $ARGX Phase X $INCY Phase X $EWTX Phase X $ROIV Phase X $GLPG Phase X $MGNX Phase X $BHVN Phase X $BHVN Phase X $ZNTL Phase X $IOVA Phase X $GNLX Phase X $RXRX Phase X $PRTA Phase X $VALN Phase X $CGON Phase X $GNLX Phase X $EXEL Phase X $PCSA Phase X $IMVT Phase X $BMEA Phase X $EXEL Phase X $HOOK Phase X $AMGN Phase X $INCY Phase X $BINV"
X Link 2025-11-30T21:25Z 28.1K followers, 74.3K engagements

"$AXGN 🎉 FDA approves BLA for AVANCE (acellular nerve allograftarwx) - AVANCE is now an FDA-licensed biologic for sensory mixed and motor peripheral nerve discontinuities in patients X month old - some indications granted under Accelerated Approval; confirmatory studies to follow - commercial launch in Q2 2026"
X Link 2025-12-04T14:42Z 28.1K followers, 9481 engagements

"December Biotech PDUFA Pulse: 📡 Whats on the FDA Radar $AXGN - Avance Nerve Graft - Approved ✅ $BMY - Breyanzi (lisocabtagene maraleucel) $AGIO - PYRUKYND (Mitapivat) $GSK - BLUJEPA (gepotidacin) $BCRX - ORLADEYO (berotralstat) Oral Granules $MIST - CARDAMYST (etripamil) nasal spray $INVA - Zoliflodacin $ALDX - Reproxalap $GSK - Depemokimab $OMER - Narsoplimab (OMS721) $CYTK - Aficamten $SNY - Tolebrutinib $CORT - Korlym (Relacorilant) $VNDA - Tradipitant $OTLK - ONS-5010 / LYTENAVA (bevacizumab-vikg) $TEVA - TVB-009P (denosumab) $ALVO - AVT06 proposed biosimilar to Eylea (aflibercept) $AMRX"
X Link 2025-12-04T16:53Z 28.1K followers, 8362 engagements

"December Biotech PDUFA Pulse: 📡 Whats on the FDA Radar $AXGN - Avance Nerve Graft - Approved $BMY - Breyanzi (lisocabtagene maraleucel) - Approved $AGIO - PYRUKYND (Mitapivat) $GSK - BLUJEPA (gepotidacin) $BCRX - ORLADEYO (berotralstat) Oral Granules $MIST - CARDAMYST (etripamil) nasal spray $INVA - Zoliflodacin $ALDX - Reproxalap $GSK - Depemokimab $OMER - Narsoplimab (OMS721) $CYTK - Aficamten $SNY - Tolebrutinib $CORT - Korlym (Relacorilant) $VNDA - Tradipitant $OTLK - ONS-5010 / LYTENAVA (bevacizumab-vikg) $TEVA - TVB-009P (denosumab) $ALVO - AVT06 proposed biosimilar to Eylea"
X Link 2025-12-05T16:48Z 28.1K followers, 65.5K engagements

"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q4 2025 (1/2). $STOK Phase X $HRMY Phase X $RXRX Phase X $XCUR Phase X $IMMP Phase 2/3 $PVLA Phase X $LTRN Phase X $COGT Phase X $NKTR Phase 2b $RZLT Phase X $INSM Phase X $KMDA Phase X $MREO Phase X $RHHBY Phase X $TRAW Phase X $RARE Phase X $GPCR Phase 2b $ZBIO Phase X $SLS Phase X $MGTX Phase X $IDYA Phase 2/3 $DWTX Phase 2b $WVE Phase X $EWTX Phase X $ZYME Phase X $ZVSA Phase 2a $BHVN Phase X $VTYX Phase X $DBVT Phase X $VTGN Phase X $INBX Phase 2/3 $LSTA Phase 2a $ADVM Phase X $ALT Phase 2b $ACIU Phase X $RYTM Phase X $ATOS Phase 2"
X Link 2025-12-07T21:27Z 28.1K followers, 39.6K engagements

"📌 Biotech Stock News 12/10 @ Open $TERN XX% $650M Offering $DYN X% $350M Public Offering $BRNS X% VTP-1000 Trial Update $MDWD X% Clinical Data on NexoBrid's Effectiveness $GPCR X% Pricing of $650M Offering $SGMT X% Denifanstat NDA Accepted by China NMPA $PTCT X% Health Canada Approves Sephience $ALC X% Response to Increased Acquisition Price $LXRX X% ACSL5 Preclinical Data Publucation $PFE X% TUKYSA Extends Survival 8mths $LLY X% Build $6B facility in Alabama $KYMR X% $602M Offering $AMRX X% Epinephrine Injection FDA Approval $NCNA -X% NUC-7738 Latest Data $PRAX -X% Elsunersen Accelerated"
X Link 2025-12-10T16:32Z 28.1K followers, 1691 engagements

"📌 Biotech Stock News 12/12 @ Open $CELC X% Updated results from VIKTORIA-1 trial $IBRX X% Conditional Authorization for ANKTIVA $BYSI X% Plinabulin+Docetaxel Improves Survival $ATNM X% ATNM-400 Data; Advances Trop-2 RadioTx $RLAY X% Efficacy Analysis of Zovegalisib $KYMR X% Closing of $602M Offering $CYTK X% Positive CHMP Opinion for MYQORZO $CRNX X% First Patient Dosed in Atumelnant Trial $MRK X% Positive EU Opinion for WINREVAIR $DYN X% Closing of Upsized Public Offering $INVA X% Positive Zoliflodacin Ph3 Data $GPCR X% Closing of $747.5M Offering $ACAD X% FDA Approval of DAYBUE STIX $EBS"
X Link 2025-12-12T16:33Z 28.1K followers, 2987 engagements

"$CELC up X% 📈 Gedatolisib triplet shows strong PFS benefit Wild-type cohort outperforms fulvestrant alone Safety manageable; stomatitis resolves quickly Don't miss out on future Big Movers Access our FREE Big Mover Report 👇"
X Link 2025-12-12T16:33Z 28.1K followers, 1150 engagements

"📣 Biotech Stock News 8/12 @ Open $ELTX XX% Publication of ELI-002 Ph1 Data $AMPH X% Bolsters Proprietary Pipeline $NVCT X% Initiation of Phase 1b Program $RCEL X% Completes Australian Equity Raise $NRXP X% FDA Fast Track for Depression Therapy $ANIX X% Issuance of Patent for CAR-T Technology $ANTX X% First-in-Human Trial of AN2-502998 $MRK X% Improved Survival for Bladder Cancer Patients $PFE X% Improves Survival for Bladder Cancer $CUBE X% Pricing of Senior Unsecured Notes $MIRA X% Second Manuscript Accepted on Ketamir-2 $LGVN -X% Closing of $XXXX Million Offering $OCUL -X% FDA Agreement"
X Link 2025-08-12T15:33Z 28.1K followers, 7110 engagements

"🧬 Biotech Stock News 08/12 Brought to you by Barb X stocks on the rise 📈 $ELTX $AMPH $NVCT X under pressure 📉 $AZTR $AARD $VERU Catch the full breakdown in the latest video 🎥"
X Link 2025-08-12T17:14Z 28.1K followers, 3249 engagements

"🧬 Biotech Stock News 08/19 Brought to you by Barb X stocks on the rise 📈 $EVFM $IOVA $PTCT X under pressure 📉 $ALXO $BTAI $VKTX Catch the full breakdown in the latest video 🎥"
X Link 2025-08-19T17:09Z 28.1K followers, 3861 engagements

"🧬 Biotech Stock News 9/5 @ Open $ADAG X% ADG126 Highlighted at CSCO Meeting $HCM X% Clinical Data Presentation at CSCO $CGON X% 24-month Durability and Tolerability Data $MLYS X% Subgroup Analyses of Ph3 Trial $MLYS X% Closing of $287.5M Offering $RGNX X% 12-month Pivotal Data from RGX-121 Trial $AVDL X% New Data on LUMRYZ $GILD X% Partnership for HIV Prevention Initiative $MDT X% Robotic Surgery System Meets Safety Endpoints $RHHBY X% New Data on Vabysmo for Wet AMD $THTX X% Availability of EGRIFTA WR for Injection $QURE X% Initial AMT-191 Phase 1/2a Data $AMRX -X% FDA Approval for"
X Link 2025-09-05T16:59Z 28.1K followers, 6770 engagements

"🧬 Biotech Stock News 09/05 Brought to you by Barb X on the rise 📈 $ADAG X% $HCM X% $CGON X% X under pressure 📉 $AMRX -X% $PALI -X% $DRUG -X% Catch the full breakdown in the latest video 🎥"
X Link 2025-09-05T21:06Z 28.1K followers, 4034 engagements

"🧬 Biotech Stock News 09/17 Brought to you by Barb On the rise 📈 $ROIV XX% $ORKA10% $ELTX9% Under pressure 📉 $RNTX-3% $CING-3% $PALI-6% Catch the full breakdown in the latest video"
X Link 2025-09-17T19:00Z 28.1K followers, 3965 engagements

"📌 Biotech Stock News 09/26 @ Open $CRNX XX% FDA Approval of PALSONIFY for Acromegaly $GUTS XX% REMAIN-1 Midpoint Cohort Data $AMRX X% BLA Submission of Xolair Biosimilar $SNY X% Expands Patient Affordability Program $KALV X% New EKTERLY Data at Allergy Congress $CDTX X% First Participants Dosed in Ph3 Trial $KURA X% Publication of Ziftomenib Data in AML $LLY X% Marketing Authorization for Alzheimer's treatment $LLY X% FDA Approves Inluriyo for Breast Cancer $ABBV X% NDA Submission for Tavapadon $THTX X% Completion of Acquisition by Future Pak $AMGN X% $650M U.S. Manufacturing Expansion $REGN"
X Link 2025-09-26T16:12Z 28.1K followers, 7253 engagements

"🧬 Biotech Stock News 09/26 Brought to you by Barb On the rise 📈 $CRNX XX% $GUTS XX% $AMRX X% Under pressure 📉 $AMGN -X% $REGN -X% $QURE -X% Catch the full breakdown in the latest video"
X Link 2025-09-26T18:18Z 28.1K followers, 3256 engagements

"📢 M&A News: Ipsen $IPSEY to acquire ImCheck Therapeutics for 1B 💵 350M upfront + milestones up to 1B; 🔬 ICT01: BTN3A-targeting antibody in Ph2/3 asset for first-line unfit AML 2x higher response rates vs. historical Ven-Aza standard 🗓 Transaction is expected to close by the end of Q1 2026; pivotal trial planned for 2026. See image for more details 👇"
X Link 2025-10-22T14:25Z 28.1K followers, 6449 engagements

"🧬 Biotech Stock News 10/22 Brought to you by Barb On the rise 📈 $GRTX XX% $IXHL X% $OSTX X% Under pressure 📉 $RAPT -XX% $ALEC -XX% $ARCT -XX% Catch the full breakdown in the latest video"
X Link 2025-10-22T17:31Z 28.1K followers, 3703 engagements

"📢 M&A News: $LLY to Acquire $ADVM $3.56/sh upfront + up to $8.91/sh CVR valuing the deal at up to $1.3B Adds Ixo-vec a one-time intravitreal gene therapy for wet AMD Ph3 (ARTEMIS trial) with Fast Track RMAT and PRIME designations $LLY provided $65M bridge financing to fund ongoing trials ahead of deal close in Q4 2025 See images for more details 👇"
X Link 2025-10-24T14:14Z 28.1K followers, 3692 engagements

"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q4 2025 (1/3). $LQDA Phase X $ATAI Phase 2b $IDYA Phase X $IDYA Phase 2/3 $VOR Phase X $KYTX Phase X $VOR Phase X $IFRX Phase 2a $IFRX Phase 2b $JAGX Phase X $VRCA Phase X $ELDN Phase X $VERA Phase X $EVAX Phase X $ALXO Phase X $ALT Phase 2b $VOR Phase X $KZR Phase 2a $ARTV Phase 2a $NKTR Phase 2b $RZLT Phase X $PVLA Phase X $IMMP Phase 2/3 $ALDX Phase X $TLPH Phase X $INAB Phase X $ALNY Phase X $LLY Phase X $BBIO Phase X $FBIO Phase X $IONS Phase X $REGN Phase 2/3 $CALT Phase X $JAZZ Phase X $GNFT Phase X $NAMS Phase X $PBYI Phase 2"
X Link 2025-10-26T19:50Z 28.1K followers, 28.9K engagements

"📌 Biotech Stock News 10/29 @ Open $PPBT XX% IM1240 Manufacturing Milestone $PDSB XX% Seek Expedited Approval for PDS0101 $ANAB X% Rosnilimab Ph2b Trial Results $BBIO X% Encaleret Ph3 Results $TMO X% To acquire Clario Holdings $TBPH X% Ampreloxetine Data @ 36th AAS $OPK X% Research Collab w/ Regeneron $LLY X% $1.2B Investment in Manuf. in Puerto Rico $RLFTF X% RLF-OD032 Bioequivalence Study $RHHBY X% Elecsys Dengue Ag test CE mark $IMAB X% Transitions to NovaBridge Biosciences $MRK X% LEAP-012 Update; KEYTRUDA EU Approval $ARGX X% VYVGART New Data @ AANEM'25 $BMRN X% PALYNZIQ sBLA FDA"
X Link 2025-10-29T16:47Z 28.1K followers, 10.3K engagements

"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q4 2025 (1/3). $IFRX Phase 2a $IFRX Phase 2b $VERU Phase 2b $JAGX Phase X $VRCA Phase X $ELDN Phase X $VERA Phase X $EVAX Phase X $SMMT Phase X $ALXO Phase X $ALT Phase 2b $VOR Phase X $KZR Phase 2a $ARTV Phase 2a $NKTR Phase 2b $RZLT Phase X $PVLA Phase X $ARGX Phase X $INCY Phase X $EWTX Phase X $RNAC Phase X $ROIV Phase X $GLPG Phase X $MGNX Phase X $BHVN Phase X $PRAX Phase 2/3 $BHVN Phase X $COGT Phase X $ALKS Phase X $ZNTL Phase X $IOVA Phase X $IOVA Phase X $GNLX Phase X $COYA Phase X $RXRX Phase X $PRTA Phase X $VALN Phase X $CGON"
X Link 2025-11-02T19:39Z 28.1K followers, 29.8K engagements

"🧬 Biotech Stock News 11/3 @ Open 1/3 🧵 $TERN XX% Clinical Data for TERN-701 at ASH $PHIO XX% Positive Pathology Results for Skin Cancer Trial $RNTX XX% FDA Clears Phase X Trial Resumption $MOLN XX% Additional preclinical proof-of-concept data; Updated data from Phase 1/2a trial $CRBU XX% Positive Data from ANTLER Phase X Trial; Positive Data from CaMMouflage Phase X $THAR XX% Private Placement of $XXX Million $VTGN XX% Completes Phase X Study for Anxiety $BLTE X% Conditional Marketing Authorization for Tinlarebant $CYDY X% $XX Million Commitment Secured $HCM X% Highlights Pipeline and"
X Link 2025-11-03T16:20Z 28.1K followers, 6617 engagements

"📌 Biotech Stock News 11/7 @ Open $THAR XX% Closes $545M Private Placement $BCAB X% Median OS of XXXX months in Sarcomas $AKBA X% Vafseo Post Hoc Data $HALO X% FDA Approves DARZALEX Faspro $AZN X% NATRON Ph3 trial results $CNTX X% CT-95 and CT-202 Programs $ELTX X% Cytolytic T Cell Responses in Trial $TMO X% Authorizes $5B Share Repurchases $MIRM X% Leadership in Liver Disease Innovation $AKRO X% New Analyses from Ph2b Trials $IMCR X% Ph1 data for hepatitis B $INKT X% Durable Responses with Allo-iNKT Tx $HCWB X% Preclinical Data @ SITC'25 $JNJ X% First FDA-approved treatment for myeloma $ASMB"
X Link 2025-11-07T16:12Z 28.1K followers, 2788 engagements

"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q4 2025 (1/3). $IFRX Phase 2a $IFRX Phase 2b $VRCA Phase X $KZR Phase 2a $CRDL Phase X $ARTV Phase 2a $ACLX Phase X $IRON Phase X $NUVL Phase X $XCUR Phase X $PVLA Phase X $NKTR Phase 2b $RZLT Phase X $ARGX Phase X $INCY Phase X $EWTX Phase X $RNAC Phase X $ROIV Phase X $GLPG Phase X $MGNX Phase X $BHVN Phase X $PRAX Phase 2/3 $BHVN Phase X $COGT Phase X $ALKS Phase X $ZNTL Phase X $IOVA Phase X $GNLX Phase X $COYA Phase X $RXRX Phase X $PRTA Phase X $VALN Phase X $CGON Phase X $GNLX Phase X $EXEL Phase X $COGT Phase X $PCSA Phase X $IMVT"
X Link 2025-11-09T19:44Z 28.1K followers, 33.9K engagements

"$DAWN $MRSN 🔥 Day One Biopharmaceuticals is set to acquire Mersana Therapeutics - deal worth up to $285M - shareholders receive $25/sh cash upfront plus up to $30.25/sh potential CVR - payouts tied to key milestones for Emi-Le & an existing collaboration MRSN lead asset: - Emi-Le is a B7-H4directed Dolasynthen ADC being developed for triple-negative breast cancer & adenoid cystic carcinoma - closing expected by Jan 2026"
X Link 2025-11-13T15:24Z 28.1K followers, 6265 engagements

"Avoro Capital 🔔 🐳 Q3 25* Holdings Released Holdings: XX Holdings in Top 20: XXXXX% Qtr over Qtr Change**: XXXXX% Top Holdings: $ASND $UTHR $MDGL $ARGX $KRYS $ARWR $KYMR $MRUS $RNA $APLS $CNTA $QURE $XENE $AKRO $VERA $SLNO $GPCR $TRML $OCUL $FOLD *Holdings as of 9/30/25 in SEC form 13F **Change in value of public company shares held See image for more details 👇"
X Link 2025-11-14T16:23Z 28.1K followers, 7407 engagements

"RA Capital 🔔 🐳 Q3 25* Holdings Released Holdings: XX Holdings in Top 20: XXXXX% Qtr over Qtr Change**: XXXXX% Top Holdings: $ASND (25.0%) $RYTM (7.1%) $PCVX (5.3%) $RNA (4.6%) $CDTX (4.0%) $SION (3.8%) $ETNB (3.6%) $NAMS (3.6%) $MLYS (3.4%) $JANX (3.4%) $ACLX (3.1%) $LENZ (2.4%) $TYRA (2.1%) $EWTX (2.1%) $WVE (1.6%) $SEPN (1.6%) $DNTH (1.4%) $BCAX (1.4%) $GHRS (1.4%) $SPRY (1.3%) *Holdings as of 9/30/25 in SEC form 13F **Change in value of public company shares held See image for more details 👇"
X Link 2025-11-14T22:38Z 28.1K followers, 9587 engagements

"OrbiMed Advisors 🔔 🐳 Q3 25* Holdings Released Holdings: XXX Holdings in Top 20: XXXXX% Qtr over Qtr Change**: XXXX% Top Holdings: $EWTX (5.9%) $BSX (5.6%) $LLY (5.4%) $SINX (4.3%) $ELVN (3.8%) $ALNY (3.2%) $SYK (3.1%) $EW (3.1%) $ISRG (3.0%) $ARGX (3.0%) $SION (2.6%) $UPB (2.5%) $IRON (2.2%) $CAI (2.2%) $SPRY (2.0%) $RNA (1.7%) $MBX (1.6%) $CGON (1.6%) $NTRA (1.6%) $AXSM (1.5%) *Holdings as of 9/30/25 in SEC form 13F **Change in value of public company shares held See image for more details👇"
X Link 2025-11-14T23:00Z 28.1K followers, 9349 engagements

"Baker Brothers Advisors 🔔 🐳 Q3 25* Holdings Released Holdings: XX Holdings in Top 20: XXXXX% Qtr over Qtr Change**: XXXXX% Top Holdings: $ONC (22%) $INCY (19%) $MDGL (7.1%) $INSM (7%) $ACAD (6.6%) $SMMT (5%) $RYTM (4.1%) $RVMD (3.2%) $CELC (2.8%) $KYMR (2.7%) $KOD (2%) $ALKS (1.8%) $ABCL (1%) $EWTX (0.9%) $KNSA (0.8%) $STOK (0.8%) $IMTX (0.7%) $GRAL (0.7%) $IDYA (0.6%) $IMVT (0.6%) *Holdings as of 9/30/25 in SEC form 13F **Change in value of public company shares held"
X Link 2025-11-14T23:19Z 28.1K followers, 19.8K engagements

"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q4 2025 (1/3). $INAB Phase X $CRDL Phase X $ACLX Phase X $IRON Phase X $NUVL Phase X $XCUR Phase X $STOK Phase X $GLPG Phase X $NRIX Phase X $PVLA Phase X $COGT Phase X $NKTR Phase 2b $RZLT Phase X $ARGX Phase X $INCY Phase X $EWTX Phase X $RNAC Phase X $ROIV Phase X $GLPG Phase X $MGNX Phase X $BHVN Phase X $PRAX Phase 2/3 $BHVN Phase X $ZNTL Phase X $IOVA Phase X $GNLX Phase X $RXRX Phase X $PRTA Phase X $VALN Phase X $CGON Phase X $GNLX Phase X $EXEL Phase X $PCSA Phase X $IMVT Phase X $BMEA Phase X $EXEL Phase X $JAZZ Phase X $HOOK"
X Link 2025-11-16T20:34Z 28.1K followers, 31.4K engagements

"🧬 Biotech Weekly News Largest single-day stock moves during the week ending 11/21/25 📈 $RPTX XX% XenoTherapeutics to acquire $RPTX $ANVS XX% New Biomarker Data on Cognitive Decline $ZYME XX% Positive Ph3 Results for HER2 Agent $VNDA XX% Tradipitant Results Reported $CTXR XX% Advance Commercial Launch with AI 📉 $AGIO -XX% Topline Results RISE UP Trial $KTTA -XX% Ph1 Data for PAS-004 $HCWB -XX% HCW9302 FIH trial Initiation $PHGE -XX% 1-for-19 Reverse Stock Split $ENSC -XX% FDA Feedback on PF614 See image below. ***** $AGIO sat under $XX this week. See @seedy19trons post for why its being"
X Link 2025-11-21T22:59Z 28.1K followers, 9520 engagements

"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q4 2025 (1/2). $INAB Phase X $CRDL Phase X $LGVN Phase 2a $INMB Phase X $ACLX Phase X $IRON Phase X $XCUR Phase X $STOK Phase X $GLPG Phase X $NRIX Phase X $PVLA Phase X $COGT Phase X $NKTR Phase 2b $RZLT Phase X $ARGX Phase X $INCY Phase X $EWTX Phase X $ROIV Phase X $GLPG Phase X $MGNX Phase X $BHVN Phase X $PRAX Phase 2/3 $BHVN Phase X $ZNTL Phase X $IOVA Phase X $GNLX Phase X $RXRX Phase X $PRTA Phase X $VALN Phase X $CGON Phase X $GNLX Phase X $EXEL Phase X $PCSA Phase X $IMVT Phase X $BMEA Phase X $EXEL Phase X $HOOK Phase X $RYTM"
X Link 2025-11-23T20:38Z 28.1K followers, 39.7K engagements

"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q4 2025 (2/2). $CGON Phase X $VTYX Phase X $DBVT Phase X $PHVS Phase X $VTGN Phase X $PRAX Phase X $INBX Phase 2/3 $MLTX Phase X $BLTE Phase X $ADVM Phase X $ALT Phase 2b $INSM Phase X $KMDA Phase X $MREO Phase X $ATOS Phase X $RHHBY Phase X $TRAW Phase X $RARE Phase X $GPCR Phase 2b $ZBIO Phase X $ADCT Phase X $SLS Phase X $PCVX Phase X $IMMP Phase 2/3 $ALDX Phase X $ALNY Phase X $LLY Phase X $FBIO Phase X $IONS Phase X $REGN Phase 2/3 $CALT Phase X $GNFT Phase X $NAMS Phase X $PBYI Phase X $KZIA Phase X $NVS Phase X $NAMS Phase X $DNLI"
X Link 2025-11-23T20:38Z 28.1K followers, 1414 engagements

"📌 Biotech Stock News 11/25 @ Open $AUTL XX% Treatment Option for R/R B-ALL $CTXR X% Exhibit at ASH Annual Meeting $BIIB X% Completes Rolling Submission for LEQEMBI $XENE X% New Azetukalner OLE Study Data $LLY X% Data from Phase X studies presented $BMY X% Approval to Expand CAR T Therapy $RAPP X% New Phase 2a Data Analysis $SRPT X% Approval for ENDEAVOR Cohort X $REGN X% First Targeted Medicine Approved for CSU $TLSA X% Nasal Foralumab Phase X Trial Accepted $TEVA X% EU Commission approvals for biosimilars $TELO X% New Data Reduces PSA Levels $NVCT -X% Virtual Meeting on NXP900 Program $NUVL"
X Link 2025-11-25T17:13Z 28.1K followers, 2515 engagements

"$XENE up X% 📈 Azetukalner long-term OLE data @ AES 2025 48mt update shows extended seizure-free periods Posters also cover depression burden & ASM titration challenges Don't miss out on future Big Movers Access our FREE Big Mover Report 👇"
X Link 2025-11-25T17:13Z 28.1K followers, 1233 engagements

"🧬 Biotech Stock News 12/01 @ Open $QTTB XXX% Sells Complement Inhibitor ADX-097 $MAIA XX% Open Market Purchases by CEO & Directors $BLTE X% Positive Results from Phase X Trial $PMN X% New Publication on Plasma pTau in Alzheimer's $RDHL X% Regains Compliance with Nasdaq $OMER X% Closing of Asset Purchase Agreement $AAPG X% Webcast Highlighting Key Data from ASH 2025 $BMY X% Data Showcase Hematology Pipeline Potential $VTRS X% Seeking Partnerships for Long-Acting Depot Drugs $MIRM X% First Patient Enrolled in BLOOM Study $MNKD -X% FDA Review of FUROSCIX Autoinjector $BCDA -X% Present at Heart"
X Link 2025-12-01T15:51Z 28.1K followers, 6316 engagements

"🧬 Biotech Weekly News Largest single-day stock moves during the week ending 12/5/25 📈 $CAPR XXX% Deramiocel Topline Results Reported $QTTB XX% Sells Complement Inhibitor ADX-097 $PRAX XX% Relutrigine Results; Ulixacaltamide Pre-NDA Mtg. $PHVS XX% Deucrictibant Topline Data Reported $GUTS XX% Positive 6-Month REVEAL-1 Results 📉 $JANX -XX% Ph1 JANX007 Efficacy & Safety Profile $BDTX -XX% Silevertinib Preliminary Ph2 Data $CLNN -XX% CNM-Au8 ALS Biomarker Results $TARA -XX% Pricing of $75M Offering $SPRC -XX% Entering Multi-Billion-Dollar GERD Device Market"
X Link 2025-12-05T22:17Z 28.1K followers, 12.4K engagements

"Check out our catalyst calendar 📅 & stay on top of key biopharma readouts $XBI $IBB"
X Link 2025-12-05T23:16Z 28.1K followers, 1236 engagements

"🧬 Biopharma Weekly Recap 📝 This week in biotech: China dealmaking surges obesity programs and competitive dynamics intensify FDA shifts spotlight reviews and rare disease and cell therapy updates drive focus. See interesting posts/ppl to check out 👇 @Biotech2k1 Biotech Forever X names cited with high sales estimates ($INSM $BBIO $AXSM $CRNX $CYTK $PTXG $IDYA $COGT); outlook noted as subject to change. @ohadhammer Jefferies: China biotech showing record activity and R&D productivity; key issue is program differentiation. @PearlF An updated FDA org chart from @biospace @DrSamuelBHume 5"
X Link 2025-12-06T15:00Z 28.1K followers, 26.7K engagements

"Check out this week's biotech major movers $XBI $IBB"
X Link 2025-12-06T15:02Z 28.1K followers, 1791 engagements

"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q4 2025 (2/2). $GNLX Phase X $EXEL Phase X $PCSA Phase X $BMEA Phase X $EXEL Phase X $HOOK Phase X $AMGN Phase X $INCY Phase X $BINV Phase 2a $ALDX Phase X $ALNY Phase X $LLY Phase X $FBIO Phase X $MRNA Phase X $IONS Phase X $REGN Phase 2/3 $CALT Phase X $GNFT Phase X $NAMS Phase X $KZIA Phase X $NVS Phase X $NAMS Phase X $DNLI Phase 2/3 $INKT Phase X $ADAG Phase X $CNTA Phase 2a $NAMS Phase X $CRVS Phase X $BIVI Phase 2b Check out the image for more details"
X Link 2025-12-07T21:27Z 28.1K followers, XXX engagements

"Each quarter we identify major catalyst events 🥳 Likely to move the stock +/- by XX% $GPCR Aleniglipron (GSBR-1290) $VTGN Fasedienol (PH94B) $ZBIO Obexelimab (CD19xFcyRIIb) Access our FREE Big Mover Report"
X Link 2025-12-07T21:27Z 28.1K followers, 2073 engagements

"Let's see how many of the XX biopharma-focused hedge funds hold these tickers. $GPCR 14/34 🔥 $VTGN 4/34 $ZBIO 3/34 Access our FREE hedge fund screener & search your fav tickers"
X Link 2025-12-07T21:27Z 28.1K followers, 1874 engagements

"🩸 ASH 2025 continues ending tomorrow Here are the presentations pulled from todays news: $FULC XX% Positive Results from PIONEER Trial $NRIX XX% New Data from Phase X Trial $NRIX XX% New Data on Bexobrutideg in CLL $CGEM XX% Clinical Data in AML Presentation $ACLX X% New Positive Data for iMMagine-1 Study $LYEL X% New Clinical Data on Ronde-Cel $EVAX X% New data for cancer vaccine candidate $AUTL X% Initial Clinical Data in Pediatric r/r B-ALL $ALXO X% Positive Results from Phase X Trial $ARVN X% Preclinical Data on ARV-393 and Glofitamab $IRON X% Positive Data from RALLY-MF Trial $SLS 3%"
X Link 2025-12-08T17:29Z 28.1K followers, 4905 engagements

"📌 Biotech Stock News 12/9 @ Open $XCUR XX% Burixafor Topline Data @ ASH'25 $WVE X% $250M Public Offering $TERN X% TERN-701 Ph1 Data; $400M Public Offering $ASMB X% ABI-1179 & ABI-5366 Interim Results $CRDF X% Onvansertib Data @ ASH'25 $ATOS X% Endoxifen U.S. Patent $GPCR X% $500M Public Offering $COYA X% Patients Dosed in ALSTARS Trial $TEVA X% Submits NDA for Olanzapine $ALC X% Amended Merger Agreement $JNJ X% Ph3 study supports new treatment $CTXR X% $18M Offering & Placement $OSTX X% OST-HER2 pre-Marketing Authorisation Mtg $CRIS X% Updated Data from Frontline AML Study $INCY 0%"
X Link 2025-12-10T16:17Z 28.1K followers, 2827 engagements

"🧬 Biotech Weekly News Largest single-day stock moves during the week ending 12/12/25 📈 $WVE XXX% Positive Interim Data INLIGHT Trial $GPCR XXX% Positive Topline Data ACCESS Program $KYMR XX% Positive Results Ph1b Trial $XCUR XX% Burixafor Topline Data @ ASH'25 $OCUL XX% NDA Submission Timeline for AXPAXLI 📉 $RZLT -XX% Ph3 sunRIZE Study Results $GRI -XX% Ph2a Topline Data; $8M Offering $APLT -XX% Cycle Pharma acquires Applied Therapeutics $TNYA -XX% TN-201 Clinical Hold Lifted $PHGE -XX% Discontinuation of Ph2b Trial ***** $WVE INLIGHT Trial data: ✅ -XXX% visceral fat -XXX% total fat +3.2%"
X Link 2025-12-12T23:26Z 28.1K followers, 7843 engagements